Ovarian cancer diagnosis with complementary learning fuzzy neural network

Artificial Intelligence in Medicine

Volumn 43, Issue 3, 2008, Pages 207-222

  Tan, Tuan Zea ^a   Quek, Chai ^a   Ng, Geok See ^a   Razvi, Khalil ^b  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b BASILDON HOSPITAL   (United Kingdom)

Author keywords

Complementary learning; DNA micro array diagnosis; Haemostasis blood assay diagnosis; Ovarian cancer diagnosis decision support; Proteomics diagnosis

Indexed keywords

ADAPTIVE CONTROL SYSTEMS; ARTIFICIAL INTELLIGENCE; BLOOD; COMPUTATIONAL METHODS; COMPUTER NETWORKS; CONTROL THEORY; DECISION SUPPORT SYSTEMS; DNA; EDUCATION; FEATURE EXTRACTION; FUZZY CONTROL; FUZZY NEURAL NETWORKS; GENES; IMAGE CLASSIFICATION; LEARNING ALGORITHMS; LEARNING SYSTEMS; MATHEMATICAL MODELS; METROPOLITAN AREA NETWORKS; MOLECULAR BIOLOGY; MULTITASKING; NANOSTRUCTURED MATERIALS; NETWORK PROTOCOLS; NEURAL NETWORKS; NUCLEIC ACIDS; ORGANIC ACIDS; PATTERN RECOGNITION; PHOTORESISTS; PROTEINS; SENSITIVITY ANALYSIS; TESTING;

ADAPTIVE RESONANCE THEORY (ART1); BLOOD TESTING; CLINICAL DECISION SUPPORT; COMPLEMENTARY LEARNING; COMPUTATIONAL INTELLIGENCE METHODS; CONVENTIONAL METHODS; CURRENT DETECTION; DEATH RATES; DEOXYRIBONUCLEIC ACID (DNA); DIAGNOSIS DECISION; DIAGNOSIS METHODS; EARLY DETECTION; ELSEVIER (CO); FUNCTIONAL MODELING; FUZZY ADAPTIVE; FUZZY-NEURAL; GENERAL (CO); HIGH DIMENSIONALITY; HUMAN PATTERN RECOGNITION; LATERAL INHIBITION; MICRO ARRAYS; NEW TECHNIQUES; OVARIAN CANCERS; PROTEOMICS; PROTEOMICS DATA; RESEARCH WORKS; RULE GENERATION; SENSITIVITY AND SPECIFICITY;

FUZZY LOGIC;

ARTICLE; ARTIFICIAL NEURAL NETWORK; BLOOD TESTIS BARRIER; CANCER DIAGNOSIS; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC ACCURACY; FUZZY SYSTEM; MICROARRAY ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; PROTEOMICS; SENSITIVITY AND SPECIFICITY;

ANTIGENS, NEOPLASM; DATABASES, FACTUAL; DECISION MAKING, COMPUTER-ASSISTED; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; FUZZY LOGIC; HEMATOLOGIC TESTS; HUMANS; LOGISTIC MODELS; NEURAL NETWORKS (COMPUTER); OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; PATTERN RECOGNITION, AUTOMATED; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 45249116785     PISSN: 09333657     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.artmed.2008.04.003     Document Type: Article

References (64)

1. American Cancer Society. Cancer facts and figures (2007), American Cancer Society, US
2. Jermal A., Murray T., Samuels A., Ghafoor A., Ward E., and Thun M.J. Cancer statistic 2003. CA: Cancer Journal for Clinician 13 (2003) 5-26
3. NIH, NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up, NIH Consensus Developmental Panel on Ovarian Cancer. Journal of the American Medical Association 1995;273(6):491-7.
4. Petignat P., Joris F., and Faltin D. Importance of the general practitioner in the early detection of ovarian cancer. Gynecologic Oncology 90 (2003) 491-500
5. Kurtz A.B., Tsimikas J.V., Tempany C.M.C., Hamper U.M., Arger P.H., Bree R.L., et al. Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis-report of the radiology diagnostic oncology group. Radiology 212 (1999) 19-27
6. US Preventive Services Task Force. Guide to preventive services. 2nd ed. (1996), US Department of Health and Human Services, Office of Disease Prevention and Health Promotion, Washington, DC
7. Fiorica J.V., and Roberts W.S. Screening for ovarian cancer. Cancer Control 3 2 (1996) 120-129
8. Low R.N., Saleh F., Song S.Y.T., Shiftan T.A., Barone R.M., Lacey C.G., et al. Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination-a longitudinal study. Radiology 211 (1999) 519-528
9. Guerriero S., Alcazar J.L., Ajossa S., Lai M.P., Errasti T., Mallarini G., et al. Comparison of conventional color Doppler imaging and power Doppler imaging for the diagnosis of ovarian cancer: results of a European study. Gynecologic Oncology 83 (2001) 299-304
10. Jeong Y., Outwater E.K., and Kang H.K. Imaging evaluation of ovarian masses. Radiographics 20 (2000) 1445-1470
11. Kusnetzoff D., Gnochi D., Damonte C., Sananes C., Giaroli A., di Paolo G., et al. Differential diagnosis of pelvic masses: usefulness of CA125, transvaginal sonography and echo-Doppler. International Journal of Gynecology Cancer 8 4 (1998) 315-321
12. Loyer E.M., Whitman G.J., and Fenstermacher M.J. Imaging of ovarian carcinoma. International Journal of Gynecology Cancer 9 (1999) 351-361
13. Cohen L.S., Escobar P.F., Scharm C., Glimco B., and Fishman D.A. Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction. Gynecologic Oncology 82 (2001) 40-48
14. Kurjak A., Kupesic S., Sparac V., Prka M., and Bekavac I. The detection of stage I ovarian cancer by three-dimensional sonography and power Doppler. Gynecologic Oncology 90 (2003) 258-264
15. Shaharabany Y., Akselrod S., and Tepper R. A sensitive new indicator for diagnostics of ovarian malignancy, based on the Doppler velocity spectrum. Ultrasound in Medicine & Biology 30 3 (2004) 295-302
16. Tailor A., Jurkovic D., Bourne T.H., Natucci M., Collins W.P., and Campbell S. A comparison of intratumoural indices of blood flow velocity and impedance for the diagnosis of ovarian cancer. Ultrasound in Medicine and Biology 22 7 (1996) 837-843
17. Low R.N., Carter W.D., Saleh F., and Sigeti J.S. Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, in-111-CYT-103 immunoscintigraphy and CT. Radiology 195 (1995) 391-400
18. Makhija S., Howden N., Edwards R., Kelley J., Townsend D.W., and Meltzer C.C. Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review. Gynecologic Oncology 85 (2002) 53-58
19. Pannu H.K., Cohade C., Bristow R.E., Fishman E.K., and Wahl R.L. PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation. Abdominal Imaging 39 (2004) 398-403
20. Fultz P.J., Jacobs C.V., Hall W.J., Gottlieb R., Rubens D., Totterman S.M.S., et al. Ovarian cancer: comparison of observer performance for four methods of interpreting CT scans. Radiology 212 (1999) 401-410
21. Lapchenkov V.I., Dudarev A.L., Vinokurov V.L., Yurkova L.E., and Barbanel E.Iu. Comparative evaluation of diagnostic significance of carbohydrate antigen CA125 and cancer-embryonal antigen in ovarian cancer. Vestnik Rentgenologii I Radiologii 5 (1993) 30-31 (in Russian)
22. Timmerman D. Ultrasonography in the assessment of ovarian and tamoxifen-associated endometrial pathology. PhD dissertation. Leuven University Press; 1997.
23. Zhang Z., Zhang H., and Bast Jr. R.C. An application of artificial neural networks in ovarian cancer early detection. In: Amari S.-I., Lee Giles C., Gori M., and Piuri V. (Eds). Proceedings of the IEEE international joint conference on neural networks, vol. 4 (2000), The Institute of Electrical and Electronics Engineers, Inc., US 107-112
24. Runowicz C.D. Ovarian cancer screening. American College of Medical Genetic Foundation, Genetic susceptibility to breast and ovarian cancer: assessment, counseling and testing guidelines (1999), New York State Department of Health
25. Sliutz G., Tempfer C., Kainz C., Mustafa G., Gitsch G., Koelbl H., et al. Tissue polypeptide specific antigen and cancer associated serum antigen in the follow-up of ovarian cancer. Anticancer Research 15 3 (1995) 1127-1129
26. Bozkurt N., Yuce K., Basaran M., Kose F., and Ayhan A. Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer. Obstetric Gynecology 103 1 (2004) 82-85
27. Wen W., Bernstein L., Lescallett J., Beazer-Barclay Y., Sullivan-Halley J., White M., et al. Comparison of TP53 mutations identified by oligonucleotide micro-array and conventional DNA sequence analysis. Cancer Research 60 (2000) 2716-2722
28. The University of Iowa's Cancer Center. Tumour marker tests (2002), University of Iowa. http://www.vh.org/adult/patient/cancercenter/tumormarker available http://www.vh.org/adult/patient/cancercenter/tumormarker [accessed June 20, 2006]
29. Yang S.T. Micro-array application in medicine (2002). http://binfo.ym.edu.tw/styang/seminar/medicine/array_medicine.htm available http://binfo.ym.edu.tw/styang/seminar/medicine/array_medicine.htm [accessed June 20, 2006]
30. Kohn E.C., Mills G.B., and Liotta L. Promising directions for the diagnosis and management of gynecological cancers. International Journal of Gynaecology Obstetric 83 Suppl 1 (2003) 203-209
31. Antal P., Verrelst H., Timmerman D., Moreau Y., Van Huffel S., De Moor B., et al. Bayesian networks in ovarian cancer diagnosis: potentials and limitations. Proceedings of 13th IEEE on computer-based medical systems (2000), The Institute of Electricals and Electronics Engineers, Inc., US 103-108
32. Odusanya A.A. Ovarian cancer prognosis and soft computing. In: Clark J.W., McIntire L.V., Ktonas P.Y., Mikos A.G., and Ghorbel F.H. (Eds). Proceedings of the second joint EMBS/BMES conference, vol. 1 (2002), The Institute of Electricals and Electronics Engineers, Inc., US 60-61
33. Snow P.B., Brandt J.M., and Larry Williams R. Neural network analysis of the prediction of cancer recurrence following debulking laparotomy and chemotherapy in Stages III and IV ovarian cancer. Molecular Urology 5 4 (2001) 171-174
34. Renz C., Rajapakse J.C., Razvi K., and Liang S.K.C. Ovarian cancer classification with missing data. In: Wang L., Rajapakse J.C., Fukushima K., Lee S.Y., and Yao X. (Eds). Proceedings of the ninth international conference on neural information processing, vol. 2 (2002), The Institute of Electricals and Electronics Engineers, Inc., US 809-813
35. Antal P., Fannes G., Timmerman D., Moreau Y., and De Moor B. Using literature and data to learn Bayesian networks as clinical models of ovarian tumors. Artificial Intelligence in Medicine 30 (2004) 257-281
36. 1H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis. Magnetic Resonance in Medicine 38 4 (1997) 569-576
37. Kusy M. Application of SVM to ovarian cancer classification problem. In: Rutkowski L, et al., editors. Proceedings of the international conference on artificial intelligence and soft computing. Lecture Notes in Artificial Intelligence 3070. Berlin, Heidelberg: Springer-Verlag; 2004. p. 1020-25.
38. Ben-Dor A., Bruhn L., Friedman N., Nachman I., Schummer M., and Yakhini Z. Tissue classification with gene expression profiles. In: Shamir R., Miyano S., Istrail S., Pevzner P., and Waterman M. (Eds). Proceedings of the fourth annual international conference on computational molecular biology (2000), ACM, New York 54-64
39. Loo L., Quinn J., Cordingley H., Roberts S., Hrebien L., and Kam M. Classification of SELDI-ToF mass spectra of ovarian cancer serum samples using a proteomic pattern recognizer. In: Reisman S., Foulds R., and Mantilla B. (Eds). Proceedings of IEEE 29th annual bioengineering conference (2003), The Institute of Electricals and Electronics Engineers, Inc., US 130-131
40. Petricoin III E.F., Ardekani A.M., Hitt B.A., Levine P.J., Fusaro V.A., Steinberg S.M., et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359 (2002) 572-577
41. Stevens E.V., Liotta L.A., and Kohn E.C. Proteomic analysis for early detection of ovarian cancer: a realistic approach?. International Journal of Gynecology Cancer 13 Suppl 2 (2003) 133-139
42. Tan T.Z., Quek C., Ng G.S., and Ng E.Y.K. A novel cognitive interpretation of breast cancer thermography with complementary learning fuzzy neural memory structure. Expert Systems with Applications 33 3 (2007) 652-666
43. Tan T.Z., Quek C., and Ng G.S. Ovarian cancer diagnosis by hippocampus and neocortex-inspired learning memory structures. Neural Networks 18 5/6 (2005) 818-825
44. Schummer M., Ng W., Bumgarner R., Nelson P., Schummer B., Bednarski D., et al. Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery genes over-expressed in ovarian carcinomas. Gene 238 (1999) 375-385
45. Witten I., and Frank E. Data mining: practical machine learning tools and techniques. 2nd ed. (2005), Morgan Kaufmann, San Francisco
46. Jang J.S.R. ANFIS: adaptive network based fuzzy inference systems. IEEE Transactions on System, Man and Cybernetics 23 3 (1993) 665-685
47. Shevade SK, Keerthi SS. A simple and efficient algorithm for gene selection using sparse logistic regression. Technical report. CD-02-22, Control Division, Department of Mechanical Engineering, National University of Singapore, Singapore; 2002. p. 117-576.
48. Liu H., Li J., and Wong L. A comparative study on feature selection and classification methods using gene expression profiles and proteomic patterns. Genomic Informatics 13 (2002) 51-60
49. Timm H., Döring C., and Kruse R. Different approaches to fuzzy clustering of incomplete datasets. International Journal of Approximate Reasoning 35 (2004) 239-249
50. Van Cott E.M., and Laposata M. Coagulation. In: Jacobs D.S., et al. (Ed). The laboratory test handbook. 5th ed. (2001), Lexi-Comp, Cleveland 327-358
51. Hoek J.A., Sturk A., ten Cate J.W., Lamping R.J., Berends F., and Borm J.J. Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma. Clinical Chemistry 34 (1988) 2058-2062
52. Quah K.H., and Quek C. MCES: a novel Monte Carlo evaluative selection approach for objective feature selections. IEEE Transactions on Neural Networks 18 2 (2007) 431-448
53. Al-Nafussi A. Ovarian epithelial tumours: common problems in diagnosis. Current Diagnostic Pathology 10 (2004) 473-499
54. Zhang Z., Liu Y., and Zhao T. SVM based feature screening applied to hierarchical cervical cancer detection. Proceedings of the international conference on diagnostic imaging and analysis (2002) 393-398
55. Casillas J., Cordón O., and Herrera F. Interpretability improvements to find the balance interpretability-accuracy in fuzzy modeling: an overview. In: Casillas J., Cordón O., Herrera F., and Magdalena L. (Eds). Accuracy improvements in linguistic fuzzy modeling, Studies in fuzziness and soft computing (2003), Springer-Verlag, Heidelberg 27-45
56. C2I, Centre for Computational Intelligence, http://www.c2i.ntu.edu.sg/; accessed November 28, 2007.
57. Ang K.K., and Quek C. RSPOP: rough set-based pseudo-outer-product fuzzy rule identification algorithm. Neural Computation 17 1 (2005) 205-243
58. Liu F., Quek C., and Ng G.S. A novel generic Hebbian ordering-based fuzzy rule reduction approach to mamdani neuro-fuzzy system. Neural Computation 19 6 (2007) 1656-1680
59. Tan T.Z., Quek C., and Ng G.S. Biological brain-inspired genetic complementary learning for stock market and bank failure prediction. Computational Intelligence 23 2 (2007) 236-261
60. Tan T.Z., Ng G.S., Quek C., and Koh S.C.L. Ovarian cancer prognosis by hemostasis and complementary learning. Neural Information Processing, PT 3, Proceedings. Lecture Notes in Computer Science 4234 (2006) 145-154
61. Tung W.L., and Quek C. FALCON: fuzzy neural control and decision systems using FKP and PFKP clustering algorithms. IEEE Transactions on Systems, Man and Cybernetics, Part B 34 1 (2004) 686-694
62. Quek C., and Tung W.L. A novel approach to fuzzy membership functions using the FALCON-MART architecture. Pattern Recognition Letters 22 9 (2001) 941-958
63. Tan T.Z., Ng G.S., and Quek C. A novel biologically and psychologically inspired fuzzy decision support system: hierarchical complementary learning. IEEE Transactions on Computational Biology and Bioinformatics 5 1 (2008) 67-79
64. Tan T.Z., Quek C., and Ng G.S. Chance discovery using complementary learning fuzzy neural network. Studies in Computational Intelligence 30 (2006) 117-134